| Factor |
Number(n) |
Mediansurvival(months) |
UnivariateP |
| Age |
| >60 |
21(58.3) |
28.7 |
0.13 |
| ≤60 |
15(41.7) |
21.8 |
| Sex |
| Male |
15(41.7) |
25.5 |
0.81 |
| Female |
21(58.3) |
23.5 |
| Tumourgrade |
| Well |
2(5.6) |
10.7 |
0.26 |
| Moderate |
27(75) |
27.8 |
| Poor |
7(19.4) |
21.8 |
| Mucinoushistology |
| Mucinous |
8(22.2) |
23.0 |
0.20 |
| Non-mucinous |
28(78.8) |
27.8 |
| Lymphnodemetastases |
| Yes |
26(72.2) |
23.0 |
0.12 |
| No |
10(27.8) |
32.8 |
| Pre-operativechemotherapy |
| Yes |
33(91.7) |
23.5 |
0.10 |
| No |
3(8.3) |
38.4 |
| Post-operativechemotherapy |
| Yes |
33(91.7) |
25.5 |
<0.001 |
| No |
3(8.3) |
8.6 |
| PCI |
| 1-5 |
16 |
47.2 |
0.01 |
| 6-10 |
13 |
23.5 |
| >10 |
7 |
21.8 |
| NumberofLiverLesions |
| ≥3 |
11 |
11.6 |
0.15 |
| <3 |
25 |
27.8 |
| HIPEC |
|
|
|
| Yes |
18(50) |
32.8 |
0.27 |
| No |
18(50) |
22.2 |
| EPIC |
| Yes |
20(55.6) |
23.0 |
0.15 |
| No |
16(44.4) |
38.4 |
| HIPEC+EPIC |
| Yes |
6(16.7) |
23.0 |
0.34 |
| No |
30(83.3) |
24.4 |
| ExtentofDisease |
| PCI>7andLM>3 |
18(50) |
21.8 |
0.03 |
| PCI≤7andLM≤3 |
18(50) |
38.4 |
|